Tuberculosis in drug users

D. C. Perlman, N. Salomon, M. P. Perkins, S. Yancovitz, D. Paone, Don Des Jarlais

Research output: Contribution to journalArticle

Abstract

The rise in tuberculosis (TB) has disproportionately affected specific populations. Historically, many patients with TB became iatrogenic opiate addicts through therapeutic use of these drugs for symptom control. Demographic trends reshaped the relationship between drug use and TB into one in which drug use became a risk factor for tuberculosis as a result of the overlap of epidemiological and social factors associated with both drug use and TB. The spread of human immunodeficiency virus infection has amplified the spread of TB among drug users. We review the epidemiology of TB in drug users as well as the factors relevant to screening and compliance in drug- using populations. Drug users constitute a high-risk group for whom screening, prevention of infection, diagnosis, and treatment pose particular challenges. The development of TB services capable of engaging drug users (those both in and out of drug treatment programs) has potential for disrupting a significant chain of rapid TB transmission.

Original languageEnglish (US)
Pages (from-to)1253-1264
Number of pages12
JournalClinical Infectious Diseases
Volume21
Issue number5
StatePublished - Jan 1 1995

Fingerprint

Drug Users
Tuberculosis
Pharmaceutical Preparations
Opiate Alkaloids
Drug and Narcotic Control
Therapeutic Uses
Virus Diseases
Population
Compliance
Epidemiology
Demography
HIV
Therapeutics
Infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Perlman, D. C., Salomon, N., Perkins, M. P., Yancovitz, S., Paone, D., & Des Jarlais, D. (1995). Tuberculosis in drug users. Clinical Infectious Diseases, 21(5), 1253-1264.

Tuberculosis in drug users. / Perlman, D. C.; Salomon, N.; Perkins, M. P.; Yancovitz, S.; Paone, D.; Des Jarlais, Don.

In: Clinical Infectious Diseases, Vol. 21, No. 5, 01.01.1995, p. 1253-1264.

Research output: Contribution to journalArticle

Perlman, DC, Salomon, N, Perkins, MP, Yancovitz, S, Paone, D & Des Jarlais, D 1995, 'Tuberculosis in drug users', Clinical Infectious Diseases, vol. 21, no. 5, pp. 1253-1264.
Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais D. Tuberculosis in drug users. Clinical Infectious Diseases. 1995 Jan 1;21(5):1253-1264.
Perlman, D. C. ; Salomon, N. ; Perkins, M. P. ; Yancovitz, S. ; Paone, D. ; Des Jarlais, Don. / Tuberculosis in drug users. In: Clinical Infectious Diseases. 1995 ; Vol. 21, No. 5. pp. 1253-1264.
@article{6f087541bbfe49e7befb46b492f7876b,
title = "Tuberculosis in drug users",
abstract = "The rise in tuberculosis (TB) has disproportionately affected specific populations. Historically, many patients with TB became iatrogenic opiate addicts through therapeutic use of these drugs for symptom control. Demographic trends reshaped the relationship between drug use and TB into one in which drug use became a risk factor for tuberculosis as a result of the overlap of epidemiological and social factors associated with both drug use and TB. The spread of human immunodeficiency virus infection has amplified the spread of TB among drug users. We review the epidemiology of TB in drug users as well as the factors relevant to screening and compliance in drug- using populations. Drug users constitute a high-risk group for whom screening, prevention of infection, diagnosis, and treatment pose particular challenges. The development of TB services capable of engaging drug users (those both in and out of drug treatment programs) has potential for disrupting a significant chain of rapid TB transmission.",
author = "Perlman, {D. C.} and N. Salomon and Perkins, {M. P.} and S. Yancovitz and D. Paone and {Des Jarlais}, Don",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "21",
pages = "1253--1264",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Tuberculosis in drug users

AU - Perlman, D. C.

AU - Salomon, N.

AU - Perkins, M. P.

AU - Yancovitz, S.

AU - Paone, D.

AU - Des Jarlais, Don

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The rise in tuberculosis (TB) has disproportionately affected specific populations. Historically, many patients with TB became iatrogenic opiate addicts through therapeutic use of these drugs for symptom control. Demographic trends reshaped the relationship between drug use and TB into one in which drug use became a risk factor for tuberculosis as a result of the overlap of epidemiological and social factors associated with both drug use and TB. The spread of human immunodeficiency virus infection has amplified the spread of TB among drug users. We review the epidemiology of TB in drug users as well as the factors relevant to screening and compliance in drug- using populations. Drug users constitute a high-risk group for whom screening, prevention of infection, diagnosis, and treatment pose particular challenges. The development of TB services capable of engaging drug users (those both in and out of drug treatment programs) has potential for disrupting a significant chain of rapid TB transmission.

AB - The rise in tuberculosis (TB) has disproportionately affected specific populations. Historically, many patients with TB became iatrogenic opiate addicts through therapeutic use of these drugs for symptom control. Demographic trends reshaped the relationship between drug use and TB into one in which drug use became a risk factor for tuberculosis as a result of the overlap of epidemiological and social factors associated with both drug use and TB. The spread of human immunodeficiency virus infection has amplified the spread of TB among drug users. We review the epidemiology of TB in drug users as well as the factors relevant to screening and compliance in drug- using populations. Drug users constitute a high-risk group for whom screening, prevention of infection, diagnosis, and treatment pose particular challenges. The development of TB services capable of engaging drug users (those both in and out of drug treatment programs) has potential for disrupting a significant chain of rapid TB transmission.

UR - http://www.scopus.com/inward/record.url?scp=0028818281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028818281&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 1253

EP - 1264

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -